FULGENT GENETICS, INC. Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale
FULGENT GENETICS, INC. (FLGT) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale · last filed 2021-03-08
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2020-12-31 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2020-09-30 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2020-06-30 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for the quarter ending 2020-03-31 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2020 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2019 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2018 was $0.00.
- FULGENT GENETICS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2017 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 3 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 6 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 9 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $0.00 derived: sum of 2 quarters · filed 2021-03-08 | $0.00 derived: sum of 3 quarters · filed 2021-03-08 | $0.00 10-K · filed 2021-03-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-08 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 derived: sum of 3 quarters · filed 2019-11-08 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 derived: sum of 2 quarters · filed 2019-08-12 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |